(NYSEMKT: SCPX) Scorpius Holdings's forecast annual revenue growth rate of 246.35% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Scorpius Holdings's revenue in 2024 is $2,226,721.On average, 1 Wall Street analysts forecast SCPX's revenue for 2024 to be $537,286,934, with the lowest SCPX revenue forecast at $537,286,934, and the highest SCPX revenue forecast at $537,286,934.
In 2025, SCPX is forecast to generate $915,474,339 in revenue, with the lowest revenue forecast at $915,474,339 and the highest revenue forecast at $915,474,339.